amitshah’s Activity

Tue Jul 8



amitshah published an article 9:51 AM

Why Mylan Should Buy Alkermes

The recent wave of tax inversion deals creates investment opportunities for healthcare companies headquartered in countries with low corporate tax rates. Alkermes is an attractive target and a likely suitor for this company is Mylan, which has [more]

Tue Jun 24



amitshah published an article 5:47 PM

‘Reddy’ to Consider This Generic Stock?

Dr. Reddy's is an Indian generic drug maker that is well poised for global and local growth in an environment where innovation is faltering and patent protection expiration are negatively affecting big pharma companies.

Tue Jun 10



amitshah published an article 3:57 PM

Can Pfizer Curb Its Appetite for Big Acquisitions?

Pfizer has insisted on pursuing an ' acquire to survive' strategy, which has stifled innovation at the company and in the case of its recent attempt to takeover AstraZeneca, has alienated shareholders. Perhaps it's time for management to find an [more]

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 68770
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 0
Best Pick ( 0)
Worst Pick ( 0)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to amitshah’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show amitshah’s 10 Latest Posts
The Motley Fool respects your privacy and strive to be transparent about our data collection practices. We use your information to customize the site for you, to contact you about your membership, provide you with promotional information, and in aggregate to help us better understand how the service is used. For more details, please review our Privacy Policy.